An interventional study of Values Clarification Mobile Application and Self-Reflection Mobile Application in Hoarding, sponsored by Mississippi State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-08.
Sponsored by Mississippi State University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Speech Disorders with a site in United States — 10 open to participants now, 10 under way, none of them phase 3. Speech Disorders · United States.
Among the 38 studies in Speech Disorders with a site in United States, this one is the 6th largest by enrollment of the 25 interventional ones that give a count, is one of 4 that started in 2023, is one of 22 with no phase, and was the 32nd registered.
77 studies on the registry are indexed under Speech Disorders; 20 are open to participants now.
Browse Speech Disorders studies →10 of the 38 studies in Speech Disorders with a site in United States are open now. Recruiting first, the newest first:
Boston University Charles River Campus · Sites in United States
Ages 18–50 · Healthy volunteers
Stanford University · Sites in United States
Ages 18–70
Vanessa Torrecillas · Sites in United States
Ages 18+
Boston University Charles River Campus · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 13+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 16 Speech Disorders studies recruiting now, 10 (63%) set no upper age limit and 5 (31%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3
First in 1979; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 116 is above the median of 38 across 54 interventional studies indexed under Speech Disorders.
Median enrollment 47 across the 25 interventional studies, 74 across the 13 observational. Of the 26 that completed or were terminated, 8 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 38 have an industry lead sponsor. The 10 most frequent:
Mississippi State University is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Mississippi State University has 1 study filed under Speech Disorders — fewer than ten, so there is no comparison to draw.
2 of the studies in Speech Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07264036Vanessa TorrecillasVelopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study | 2027-01-01 |
| NCT05741853Stephanie GrassoCognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 38 studies in Speech Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of the study is to investigate whether values clarification writing prompts administered via a prototype mobile application can help enhance motivation and facilitate decluttering in individuals with hoarding problems. This randomized control trial will help to (1) assess whether values clarification can improve outcomes in hoarding treatment by increasing motivation, (2) clarify which specific values clarification procedures are most beneficial, and (3) evaluate the impact of values clarification on overall symptoms and well-being. Participants will be randomly assigned to either the experimental group (receiving the values clarification intervention), psychological placebo group (self-reflection intervention), or the no intervention waitlist group.
This randomized control trial study aims to investigate the efficacy of a values clarification prototype mobile application intervention in enhancing motivation and facilitating decluttering in individuals with clinical levels of hoarding symptoms. Participants will be recruited using a variety of recruitment methods (e.g., Google Ads, posts on relevant online groups such as Facebook groups, posting flyers, and provider referrals). Interested participants will first complete a pre-screen asking about their age, country of residence, and whether they own an appropriate mobile device (i.e. iOS or Android). Eligible participants, who must be at least 18 years old and residing in the United States, will be provided with a consent form to sign and then directed to further screening to determine whether they meet the clinical cutoff for hoarding symptoms. Individuals who decline to participate or are screened as ineligible will be screened out and provided with a brief list of other resources they may access for clutter/hoarding problems. The researchers also reserve the right to screen individuals out if they are suspected to be bots or invalid participants. Individuals who consent and are screened as eligible will be redirected to complete a baseline survey and then randomly assigned to one of three groups with equal probability: (1) Experimental group with the values clarification mobile application, (2) psychological placebo group with the self-reflection mobile application, and (3) no-treatment waitlist group. Four weeks after baseline, participants will be asked to complete a post-treatment survey and eight weeks after baseline, participants will be asked to complete a final, follow-up survey. The no-treatment waitlist participants will be given the opportunity to download and use either prototype mobile app, and participants assigned to use one of the apps will be given the opportunity to use the alternative app.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will be asked to respond to values clarification prompts twice a day over 28 days \[4 weeks\]. In each session, participants will receive a randomly assigned writing prompt from a pool of four categories: hierarchical, conditional, distinction, and perspective-taking prompts. In the initial session, participants will be asked to respond to a brief set of questions pertaining to their hoarding behavior in the past 12 hours and their motivation to declutter right now. From that point on, participants will respond to a brief set of questions before each writing prompt pertaining to their hoarding behaviors in the time since the previous writing prompt. After the writing prompt, they will be asked about how motivated they are to declutter right now. Each writing prompt is anticipated to take up to 10 minutes to complete and participants will receive notifications to use the app twice daily in addition email reminders twice a week to engage with the app.
Behavioral: Values Clarification Mobile Application
Participants in this condition will be asked to respond to a set of randomly selected self-reflection prompts twice a day over 28 days \[4 weeks\]. As with the experimental condition, participants in the initial session will be asked to respond to a brief set of questions pertaining to their hoarding behavior in the past 12 hours and their motivation to declutter right now. From that point on, participants will be asked to respond to a brief set of questions before each writing prompt pertaining to their hoarding behaviors in the time since the previous writing prompt. After the writing prompt, they will be asked about how motivated they are to declutter right now. Each writing prompt is anticipated to take up to 10 minutes to complete, and participants will receive notifications to use the app twice daily in addition to email reminders twice a week to engage with the app.
Behavioral: Self-Reflection Mobile Application
Participants assigned to the waitlist will not receive access to any intervention for 8 weeks. After 8 weeks, they will receive access to either the values clarification or self-reflection mobile application.
Participants in the intervention group will be asked to answer a series of values clarification writing prompts twice a day over four weeks.
Participants in the psychological placebo group will be administered writing prompts in the same format and frequency as the values intervention, but with prompts focused on self-reflection related to clutter and organization.
Saving Inventory - Revised (SI-R; Frost et al., 2004)
A self-report measure of hoarding symptoms grouped into three factors: excessive acquisition, difficulty discarding, and clutter. The SI-R consists of 23 items that are rated on a scale from 0 (e.g., no distress) to 4 (e.g., extreme distress). Scores range from 0 to 92, with higher scores indicate greater endorsement of hoarding disorder symptoms.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Sheehan Disability Scale (Sheehan, Harnett-Sheehan, & Raj, 1996)
A self-report measure of functional impairment due to symptoms. It consists of 3 items rated on a scale from 0 (not at all) to 10 (extremely). Scores range from 0 to 30, with higher scores indicate greater impairment. This measure has been adapted to ask about disability related to hoarding.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Activities of Daily Living in Hoarding Scale (ADL-H; Frost et al., 2013)
A self-report measure of activities impaired by hoarding disorder. The ADL-H consists of 15 items rated on a scale from 0 (can do it easily) to 5 (unable to do). A "not applicable" response option is also provided. Total scores range from a minimum of 0 to a maximum of 75, with higher scores indicating greater impairment.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Values Clarity Questionnaire (VCQ; McLoughlin et al., unpublished manuscript)
A self-report scale that measures how well respondents understand and can articulate their values. The VCQ consists of 7 items rated on a scale from 1 (strongly disagree) to 5 (strongly agree). Total scores range from a minimum of 7 to a maximum of 35, with higher scores indicating higher levels of clarity, understanding, and articulation of one's own values.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Valuing Questionnaire (VQ; Smout et al., 2013)
A self-report questionnaire that measures the extent to which one is living in accordance with their values. The VQ consists of 10 items rated on a scale from 0 (not at all true) to 6 (completely true). Total scores range from 0 to 60, with higher scores indicating greater valued living.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Acceptance and Action Questionnaire for Hoarding (AAQH; Krafft et al., 2019)
A self-report measure of hoarding-related psychological inflexibility. The AAQH consists of 14 items rated on a scale from 1 (never true) to 7 (always true). Total scores range from 14 to 98, with higher scores indicating greater hoarding-related psychological inflexibility.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Depression, Anxiety, and Stress Scales (DASS-21; Henry & Crawford, 2005)
A self-report measure of symptoms related to depression, anxiety, and stress. The DASS-21 consists of 21 items rated on a scale from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). Total scores range from 0 to 63, with higher scores indicating greater endorsement of depression, anxiety, and stress related symptoms.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Satisfaction with Life Scale (SWLS; Diener et al., 1985)
A self-report measure assessing one's satisfaction with their life as a whole. The SWLS consists of 5 items rated on a scale from 1 (strongly disagree) to 7 (strongly agree). Scores range from 5 to 35, with higher scores indicating greater life satisfaction.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Random responding question (used in e.g. Krafft & Levin, 2021)
Participants will be asked to choose one of the following statements that best describe their participation in the survey, noting that their answer does not impact their participation in the study in any way: "I answered every question carefully and honestly" (1); "I answered most questions carefully and honestly" (2); "I randomly responded and/or did not respond honestly to about half of the questions"(3); "I randomly responded and/or did not respond honestly to most questions"(4); and "I randomly responded and/or did not respond honestly to any questions"(5). Participants who score a 4 or 5 will be screened out for random responding.
Time frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Treatment Evaluation Inventory-Short Form (TEI-SF; Kelley et al., 1989)
A self-report measure of treatment acceptability. Only administered to the experimental and placebo conditions.The TEI-SF consists of 7 items rated from 1 (strongly disagree) to 5 (strongly agree). Scores range from 7 to 35, with higher scores indicating higher levels of endorsement for treatment acceptability.
Time frame: Posttreatment (4 weeks after baseline)
System Usability Scale (SUS; Bangor et al., 2008)
A self-report measure of usability of a technological system. The SUS consists of 10 items rated on a scale from 1 (strongly disagree) to 5 (strongly agree). Scores are summed and doubled such that they range from 0 to 100 (as per the official scoring instructions), with high scores indicated greater usability. Only administered to the experimental and placebo conditions.
Time frame: Posttreatment (4 weeks after baseline)
Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000)
A self-report measure of the perceived credibility of and expectations toward a treatment. Only administered to the experimental and placebo conditions. The CEQ consists of 6 items, 3 for Credibility and 3 for Expectancy. An average score ranging from 1 to 9 will be calculated for Credibility, with higher scores a greater perception of the intervention's credibility by the participants. For the expectancy component, an average percentage score will be calculated ranging from 0% to 100%, with higher percentages indicating more positive expectations towards the treatment.
Time frame: After using first website session (approximately 0-1 weeks after baseline)
Novel satisfaction item 1
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "What did you like best about the prototype mobile app?"
Time frame: Posttreatment (4 weeks after baseline)
Novel satisfaction item 2
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only administered to the experimental and placebo conditions. The question is, "What was the most important thing you learned from the mobile app?"
Time frame: Posttreatment (4 weeks after baseline)
Novel satisfaction item 3
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "What did you like least about the mobile app? Why did you like this the least?"
Time frame: Posttreatment (4 weeks after baseline)
Novel satisfaction item 4
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "Do you have any other comments or suggestions regarding the mobile app?"
Time frame: Posttreatment (4 weeks after baseline)
Plan to share: Yes — We plan to share fully deidentified data sets. We will remove any potentially identifying information including unusual demographics or combinations of demographics removed, but all other variables will be available to other researchers, journals or officials on reasonable request.
Supporting information: Study protocol
Time frame: Within one year of the end of data collection, and remaining available indefinitely
Access criteria: There are no specific access criteria. The request must have a valid research-related purpose.
Ran from Nov 2023 to primary completion in Nov 2024, 12 months.
Of 35 non-industry interventional studies with no phase under Speech Disorders, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 38. This study's 12 months is below that.
Counting every sponsor, half of 37 studies reached it within 28 months; a quarter within 17 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mississippi State University